Search

Athletes at Olympic Developmental Program (ODP) camps experience unusually high levels of expectations and inherent mental and physical challenges within such a short span of time. With the increasing emphasis on talent development, there has been consensus by the ODP staff to more clearly define present levels of coping skills, in order to enhance athletic prediction, maximize training efforts, identify the predisposition to injury, and focus on areas pertinent to successful performance. This study examined athletic and pain coping skills of U.S. ODP soccer athletes not previously investigated. Following written informed consent, 70 males completed the Athletic Coping Skills Inventory and the Sports Inventory for Pain. Data were analyzed by competitive level (U-14, U-15), and skill position (goalkeeper/defense, midfield/foward). MANOVA indicated a significant main effect across competitive level (Wilks' Lambda F12.57 = 2.27; p = 0.02; n-β = 0.915) but no significant effect by skill position (Wilks' Lambda F12.57 = 0.931; p = 0.523; n-β = 0.457). Post hoc analyses indicated that U-15 athletes scored significantly higher in concentration (p = 0.01) and body awareness (p = 0.03), but lower in avoidance (p = 0.01) than U-14 competitors. In conclusion, older, more experienced athletes revealed more positive athletic and pain coping skills than younger, less experienced athletes, although athletes in skill positions requiring spontaneous decision-making skills and split-second adjustment in a constantly changing sport environment (forwards, midfielders) did not exhibit more positive athletic and pain coping skills than those positions requiring reaction and protection (defenders, goalkeepers). [ABSTRACT FROM AUTHOR]

Human leukocyte antigens (HLA) class I molecules restrict the interaction between cytotoxic T cells and target cells. Abnormalities in HLA class I antigen expression and/or function may provide tumor cells with a mechanism for escaping immune surveillance and resisting T cell-based immunotherapies. The potential for applying T cell-based immunotherapy in the treatment of acute myeloid leukemia (AML) has stimulated interest in analyzing HLA class I antigen expression on leukemic blasts in this disease. Little information is available in the literature. We have analyzed HLA class I antigen expression on bone marrow samples from 25 newly diagnosed AML patients by indirect immunofluorescence staining with monoclonal antibodies. Five of these patients were also studied at relapse. Leukemic blasts were resolved from normal lymphocytes by staining with antiCD45 antibody; CD45 expression is dim on leukemia cells, but bright on lymphocytes. HLA class I antigen expression was higher on leukemic blasts than on autologous lymphocytes in all but one case. Moreover, there was no significant change in HLA class I antigen expression at relapse. These results suggest that abnormalities in HLA class I antigens are infrequent in AML and should not represent a major obstacle to the application of T cell-based immunotherapies in this disease. [ABSTRACT FROM AUTHOR]

11q23 translocations (t(11q23)) are recurring cytogenetic abnormalities in both acute myeloid leukemia (AML) and acute lymphoblastic leukemia, involving the same gene, ALL1 (or MLL). Mixed lineage antigen expression has been reported in these leukemias, but its frequency and clinical significance are unknown. We immunophenotyped leukemia cells from 19 adult de novo AML patients with t(11q23) by multiparameter flow cytometry. Translocations included t(6;11)(q27;q23), t(9;11)(p22;q23), t(9;11;19)(p22;q23;q13.3), t(2;11)(11;17)(q37;q11q23;q11), t(11;17)(q23;q25), t(11;19)(q23;p13.1), t(11;19)(q23;p13.3) and t(11;22)(q23;q11). FAB types were M4 and M5. The committed stem cell and myeloid antigens HLADr, CD4dim, CD11b, CD13, CD15, CD32, CD33, CD38 and CD64 were each expressed in 80-100% of cases, and the early stem cell and lymphoid antigens CD34, CD56, CD3, CD2 and CD7 in 42, 39, 16, 5 and 5%, respectively. Antigen expression frequencies did not differ from those in 443 adequately karyotyped M4 and M5 cases without t(11q23). Fifteen patients (79%) attained complete remission (CR); median CR duration and survival were 10.0 and 15.1 months. CR duration and survival did not correlate with antigen expression. In particular, patients with t(9;11) survived longer than those with other t(11q23) (median not reached vs 7.6 months; P = 0.048), but antigen expression did not differ in the two groups. Thus frequencies of lymphoid antigen expression are similar in AML with t(11q23) and in other FAB M4 and M5 cases, treatment outcome does not differ in t(11q23) cases with and without lymphoid antigen expression, and better outcome of patients with t(9;11) compared to other t(11q23) does not correlate with differences in antigen expression. Mixed lineage antigen expression is not a distinctive feature of AML with t(11q23). [ABSTRACT FROM AUTHOR]

The article presents a study which highlights the role of school counselors in school management and organization in the U.S. Previous studies revealed that student counselors are often loaded with responsibilities that are far related to counseling theory and practice such as clerks and attendance accountants. This study aims to cite the practical functions of counselors which concentrate on counseling of personal, educational and vocational problems. Furthermore, it proposes a bill of rights which corresponds to the role of school counselors.